Home
Vir Biotechnology VIR paid Forbes-Tate $70K for lobbying in Q4 2023 · Health Issues, Government Issues and 2 more issues
Trade details
- Type
- Lobbying report
- Amount
- $70,000
- Quarter
- Q4 2023
- Client
- Vir Biotechnology
- Reported
- 24/01/16
Down 12.5% from last quarter
What else happened in Vir Biotechnology around then
Filed or reported within 30 days of the trade day · 23/12/01~24/01/30Vir Biotechnology's other lobbying reports
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 07/20
for Q2
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 04/19
for Q1
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 01/17
for Q4 2025
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 25/10/18
for Q3 2025
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 25/07/18
for Q2 2025